Effect of one-year highly active antiretroviral therapy on HIV/AIDS immune reconstruction
Zi Chen
Abstract
Zi Chen
Abstract
Objective To investigate the impact of one-year highly active antiretroviral therapy(HAART) on antiviral effect and immune reconstruction in HIV/AIDS patients.Methods Thirty-five HIV/AIDS patients were initially treated with HAART when CD4+T cells were 350/μL,blood samples were taken at the HAART time point 0,6,12 months,the virus load was tested by RT-PCR,CD4+T cells,CD8+T cells,CD4+ naive cells,CD4+ memory cells and CD8+ activated cells were detected by flow-cytometry.Results The average virus load of 35 patients was(4.62±1.09)×106 copies/mL before HAART,and was lower than the lower limit of detection value after HAART for 6 months and 12 months.The levels of CD4+ T cells,CD4+ naive cells and CD4+ memory cells were(312±109.22) /μL,(150±57.34)/μL and(212±48.06)/μL respectively after HAART for 12 months,while they were(183±83.73)/μL,(73±20.40)/μL and(119±30.42)/μL respectively at the baseline(P0.01),but they were still lower than healthy control group([768±146.41]/μL,[424±87.06]/μL and [442±61.40]/μL,respectively)(P0.05);the level of CD8+ T cells were(427±99.79)/μL after HAART,which decreased significantly compared with(597±111.43)/μL of the baseline(P0.05),but still higher than(208±37.39)/μL of healthy control group(P0.05).Conclusion HAART can both inhibit virus replication rapidly and reconstruct HIV/AIDS patients' immunity partially.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the impact of one-year highly active antiretroviral therapy(HAART) on antiviral effect and immune reconstruction in HIV/AIDS patients.Methods Thirty-five HIV/AIDS patients were initially treated with HAART when CD4+T cells were 350/μL,blood samples were taken at the HAART time point 0,6,12 months,the virus load was tested by RT-PCR,CD4+T cells,CD8+T cells,CD4+ naive cells,CD4+ memory cells and CD8+ activated cells were detected by flow-cytometry.Results The average virus load of 35 patients was(4.62±1.09)×106 copies/mL before HAART,and was lower than the lower limit of detection value after HAART for 6 months and 12 months.The levels of CD4+ T cells,CD4+ naive cells and CD4+ memory cells were(312±109.22) /μL,(150±57.34)/μL and(212±48.06)/μL respectively after HAART for 12 months,while they were(183±83.73)/μL,(73±20.40)/μL and(119±30.42)/μL respectively at the baseline(P0.01),but they were still lower than healthy control group([768±146.41]/μL,[424±87.06]/μL and [442±61.40]/μL,respectively)(P0.05);the level of CD8+ T cells were(427±99.79)/μL after HAART,which decreased significantly compared with(597±111.43)/μL of the baseline(P0.05),but still higher than(208±37.39)/μL of healthy control group(P0.05).Conclusion HAART can both inhibit virus replication rapidly and reconstruct HIV/AIDS patients' immunity partially.
Key concepts: CD8, Viral load, Immune system, Flow cytometry, Antiretroviral therapy, Virus, Immunology, Medicine